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Abstract
Patients at short-term risk of paroxysmal atrial fibrillation (PAF) often exhibit increased RR interval variability during sinus
rhythm. We studied if RR dynamic analysis, applied in the first hours after stroke unit (SU) admission, identified acute ischemic
stroke patients at higher risk for subsequent PAF episodes detected within the SU hospitalization. Acute ischemic stroke patients
underwent continuous cardiac monitoring (CCM) using standard bedside monitors immediately after SU admission. The CCM
tracks from the first 48 h were analyzed using a telemedicine service (SRA clinic, ApoplexMedical, Germany). Based on the RR
dynamics, the stroke risk analysis (SRA) algorithm stratified the risk for PAF as follows: low risk for PAF, high risk for PAF,
presence of manifest AF. The subsequent presence/absence of PAF during the whole SU hospitalization was ruled out using all
available CCMs, standard ECGs, or 24-h Holter ECGs. Two hundred patients (40% females, mean age 71 ± 16 years) were
included. According to the initial SRA analysis, 111 patients (56%) were considered as low risk for PAF, 52 (26%) as high risk
while 37 patients (18%) had manifest AF. A low-risk level SRAwas associated with a reduced probability for subsequent PAF
detection (1/111, 0.9%, 95% CI 0–4.3%) while a high-risk level SRA predicted an increased probability (20/52, 38.5% (95% CI
25–52%). RR dynamic analysis performed in the first hours after ischemic stroke may stratify patients into categories at low or
high risk for forthcoming paroxysmal AF episodes detected within the SU hospitalization.
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Introduction
Detection of paroxysmal atrial fibrillation (PAF) after an is-
chemic stroke is of paramount importance since patients with
AF benefit from oral anticoagulation more than from standard
antiplatelet therapy [1, 2]. The diagnosis of PAF is often chal-
lenging, as it may remain undetected on conventional ECG
and a Holter ECG as well as short-term continuous cardiac
monitoring (CCM) provided by stroke unit (SU) monitors [3,
4]. Current guidelines recommend the use of CCM at least for
the first 24–72 h after stroke [1, 2]; however, there is at present
no consensus on the optimal method and duration of CCM in
SU settings [5]. Moreover, conventional bedside monitors are
usually withheld after the first days as they severely restrict the
patient mobility and are often poor tolerated. The search for
PAF in SU can be further pursued with longer term CCM
using mobile telemetry devices, repeat Holters, and patch-
type devices [5]. However, access to these techniques is cur-
rently limited by their economic costs, the lack of standardized
approach, and organizational burden. Thus, a large number of
stroke patients with undiagnosed PAF may not receive an
optimal antithrombotic therapy.
* Alessandro Adami
alessandro.adami@sacrocuore.it
1 Stroke Center, Ospedale Sacro Cuore–Don Calabria, Negrar, Verona,
Italy
2 Neurology Clinic, University of Udine, Udine, Italy
3 Apoplex Medical Technologies GmbH, Pirmasens, Germany
4 Cardiology Department, Ospedale Sacro Cuore–Don Calabria,
Negrar, Verona, Italy
5 Stroke Division, Florey Institute of Neuroscience and Mental Health,
University of Melbourne, Heidelberg, Victoria, Australia
Translational Stroke Research
https://doi.org/10.1007/s12975-018-0645-8
The ability to ascertain those patients at higher AF risk
within the first days after stroke could improve the patient
selection for longer term CCM throughout the SU stay.
Clinical features (such as age, sex, the CHA2-DS2-VASc
score) and electrocardiographic or echocardiographic (left
atrial volume, premature atrial complexes, PR interval) pre-
dictors for PAF have been assessed. However, their clinical
effectiveness is unclear [6].
SRA clinic is a telemedicine service based upon RR inter-
val dynamic analysis providing automated AF detection for
SU patients [7]. The stroke risk analysis (SRA) algorithm had
been demonstrated [8, 9] able to identify abnormalities sug-
gestive of increased PAF risk in patients with a previously
diagnosed PAF but at sinus rhythm during the analysis with
a 60% sensitivity and 99% specificity. Therefore, the SRA
algorithm may be used to identify those acute stroke patients
at higher risk for forthcoming PAF episodes.
In this study, we applied SRA analysis on CCM obtained
within the initial 48 h from SU admission. We hypothesized
that this technique would identify patients at higher risk for
PAF detected during SU hospitalization.
Methods
Within an unsponsored investigator-initiated observational
study approved by the local ethical committee, we investigat-
ed unselected acute ischemic stroke and TIA patients consec-
utively admitted in a single stroke center. Enrollment was
retrospective from January 2014 to January 2015 and then
prospective until December 2016. Inclusion criteria were as
follows: stroke/TIA diagnosis confirmed by a neurologist,
hospital admission within 24 h from symptom onset, availabil-
ity of initial 48-h CCM, and availability of standard ECG or a
24-h Holter ECG or further CCM after the first days of mon-
itoring. Inability to give consent and the presence of implant-
able rhythm control devices were exclusion criteria. For all
patients, a clinical history was collected and National
Institutes of Health Stroke Scale (NIHSS) admission and
CHA2-DS2-Vasc scores calculated. Standard investigations
comprised brain CT/MRI, echocardiography, and carotid ul-
trasound study. Additional ECGs, a 24-h Holter ECG, and
further CCM monitoring were performed according to the
clinician’s discretion. Patients treated with IV thrombolysis
were admitted in the ICU department for the first 24–48 h
and initiated their initial CCM when transferred into the SU.
After SU admission, CCM for consecutive 48 h was im-
mediately initiated using standard bedside monitors
(Intellivue MP40, Philips). After 48 h, CCM was withheld
to permit mobilization unless further monitoring was deemed
clinically necessary in patients with more severe/unstable clin-
ical conditions. CCM ECG tracks were sent via a secure in-
ternet connection to the SRA server (Apoplex Medical
Technologies, Pirmasens, Germany) for the assessment of
RR interval dynamics calculated on overall 48-h recordings.
The details of SRA data processing have been previously de-
scribed [8, 9]. Briefly, the AF risk is associated with the pres-
ence of premature atrial complexes, atrial tachycardia, and
other ectopic activities. These abnormalities alter atrioventric-
ular nodal conduction and result in changes in the ventricular
response that are often not detected by conventional linear
assessment of heart rate variability. The SRA algorithm as-
sesses the AF risk in three steps. QRS complexes are first
identified on ECG to create a RR interval list. RR intervals
are normalized by dividing them by the mean of the two cor-
responding RR intervals [(Ri − Ri + 1) (Ri + Ri + 1)]. These
RR intervals are then used to calculate various, mostly non-
linear, mathematical parameters such as the following: stan-
dard deviation of the minor and major axis of the Poincaré
plots and their ratio; RR fluctuation based upon different anal-
yses of consecutive RR intervals; the number of premature
atrial complexes without sinus nodal reset. Finally, entropic
analysis of RR intervals regularity is applied.
The SRA algorithm classified initial 48-h CCM tracks as
(1) no presence of AF and low risk for AF; (2) no AF and high
risk for AF; and (3) presence of manifest episodes of AF. In
the case of detected AF, the SRA service provided source
ECG tracks for clinical confirmation of AF. SRA clinic detec-
tion of manifest AF episodes includes only episodes > 30 s.
In the presence of manifest AF on ECG data, SRA clinic has
a 99% sensitivity and specificity compared to Holter ECG [9].
At discharge, for each patient, the heart rhythm was adju-
dicated by a cardiologist as sinus rhythm/PAF/AF based on all
available ECGs, a Holter ECG, and CCM tracks (including
the SRA algorithm provided data).
Statistical Analysis
In univariate analysis, we compared the risk factors that were
different between patients at low risk of AF, at high risk of AF,
and with manifest AF, using ANOVA for continuous data
(age, NIHSS, QTc interval) and the Pearson chi-square test
for categorical data. Pairwise post hoc comparisons were per-
formed with the Bonferroni correction. We subsequently com-
pared risk factors for subsequent diagnosis of AF in the sub-
group of patients without manifest AF on SRA clinic assess-
ment. Logistic regression was then performed in the subgroup
of patients without manifest AF on SRA clinic assessment
with presence of AF as the dependent and SRA clinic assess-
ment as low or high risk, previous diagnosis of PAF/AF and
CHA2D2-Vasc score as the independent variables. Because of
the limited number of patients with a further diagnosis of AF,
we did not further adjust for other factors. The analyses were
performed using SPSS 21.0 (IBM). A p value of 0.05 was
considered significant.
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Results
Between January 2014 and December 2016, 259 patients were
considered for inclusion in the study. Of these, 59 were excluded
for the following reasons: hospital admission later than 24 h from
symptom onset (8); lack of early CCM (23); presence of ICDs
(10); refusal/inability to participate in the study (18). Twohundred
patients (99 retrospective, 40% females, mean age 71 ± 16 years)
with ischemic stroke (n = 187) and TIA (n = 13) were finally
enrolled. Stroke/TIA etiologic TOAST classification of enrolled
patients was as follows: large artery atherosclerosis 11 (5.5%)
patients; lacunar 20 (10%); other determined etiology 9 (4.5%);
cardioembolic 62 (31%); cryptogenic (more than one cause or
incomplete evaluation) 13 (6.5%); embolic stroke of undeter-
mined source 85 (42.5%). One hundred and fifty-six patients
(77%) initiated CCM within the same day of symptom onset
while 44 patients treated with I.V thrombolysis and first admitted
to the ICU initiated CCM 24 to 48 h from hospital admission.
Table 1 presents a summary of baseline characteristics of the
patients. There were no differences in the clinical and instru-
mental findings between the retrospective and prospective pa-
tients cohort. On initial CCM, AF risk was considered low in
111 (55.5%) patients and high in 52 (26%) while 37 patients
(18.5%) had manifest AF. Significant differences among the
three groups were found with respect to age, risk factors (hy-
pertension, smoking, CHA2DS2-VASC score), stroke severity,
thrombolysis rates, and left atrial volume. The low-risk group
patients were younger compared to the high-risk (mean differ-
ence, 15.3 years, 95% CI 10–20) and the manifest AF groups
(15 years, 95% CI 9–21). The manifest AF group had a higher
baseline NIHSS compared to the low (p = 0.001) and high AF
risk groups (p = 0.001). There was no difference in NIHSS
between low and high risk AF groups. The CHA2-DS2-Vasc
scores and the QTc values were higher in the high AF and
manifest AF groups compared to the low-risk group (both
p = 0.001), but there were no significant differences between
Table 1 Patient characteristics
Patient characteristics Low AF risk,
N = 111
High AF risk,
N = 52
Manifest AF,
N = 37
p
Age (years) 65 ± 14 80 ± 8 80 ± 12 < 0.001
Sex, female 39 (35) 22 (42) 19 (51) 0.202
Current smoking 20 (18) 1 (2) 3 (8) 0.009
Hypertension 70 (63) 42 (81) 33 (89) 0.003
Diabetes 15 (13) 12 (23) 8 (22) 0.249
Dyslipidemia 44 (40) 17 (33) 10 (27) 0.338
Previous AF/PAF diagnosis 6 (5) 7 (13) 5 (13) 0.140
Antiarrhythmic drugs 24 (22) 22 (42) 18 (50) 0.001
CHA2-DS2-Vasc
Median 4.5 5 6
25th percentile 3 5 5 < 0.001
75th percentile 6 6 6
NIHSS 4 ± 5 5 ± 6 11 ± 8 0.009
QTc (ms) 430 ± 34 448 ± 29 462 ± 33 < 0.001
Thrombolysis 17 (15) 6 (12) 12 (33) 0.023
Left atrial volume
Normal (< 40 mL/m2) 65 (59) 21 (40) 4 (11)
Enlarged (40–45 mL/m2) 11 (10) 7 (13) 4 (11) < 0.001
Severely enlarged (> 45 mL/m2) 8 (7) 13 (25) 15 (41)
Not available 27 (24) 11 (21) 14 (38)
Left atrial diameter
Normal (< 39 mm) 33 (30) 12 (29) 3 (8) 0.095
Enlarged (39–50 mm) 40 (36) 19 (45) 15 (41)
Severely enlarged (> 50 mm) 5 (5) 5 (12) 4 (11)
Not available 33 (30) 6 (14) 15 (41)
Final heart rhythm
Sinus rhythm 110 (99) 32 (61.5) 0
PAF 1 (1) 20 (38.5) 12 (32) < 0.001
Permanent/persistent AF 0 0 25 (68)
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the high-risk and the manifest AF groups. There were no dif-
ferences in the rate of previously diagnosed PAF, while the use
of class I–III–IV antiarrhythmic drugs was higher in high-risk
and AF patients. The mean SU stay was 9.7 ± 4 days without
differences between the three groups.
During SU stay, AFwas evident in 58 (29%) patients, in 33
(16.5%) as paroxysmal, and in 25 (12.5%) as permanent/per-
sistent. AF was detected in 1/110 low-risk patients (0.9%;
95% CI 0–4.9%) whereas 20/52 (38.5%; 95% CI 25–52%)
of high-risk patients had a diagnosis of AF. In the detection of
AF, SRA exhibited 100% sensitivity and 97% specificity
compared to CCM. Those six patients with AF on SRA not
confirmed on source CCMwere classified as high-risk for AF.
In univariate analysis, the presence of PAF among patients
categorized as low- or high-risk of AF was associated with
SRA category, age, previous PAF/AF history, use of antiar-
rhythmic drugs, CHA2-DS2-Vasc, and QTc duration
(Table 2). In an exploratory multivariate model, after correc-
tion for CHA2DS2-VASC score and previous AF/PAF diag-
nosis, SRA risk score remained a significant predictor for a
final diagnosis of AF (Table 3).
Discussion
In this study, electrocardiographic RR dynamics analysis, per-
formed in the first 48 h from stroke unit admission, was able to
stratify patients at high or low short-term risk for PAF. Patients
at low risk with SRA analysis were unlikely to develop AF
during the stay in the SU, whereas about 1/3 patients identified
as high risk had a subsequent diagnosis of PAF. It is notewor-
thy that our analysis did not require additional investigations
but were obtained using already available data, i.e., the CCM
provided by conventional stroke unit monitors.
Table 2 Comparison between
patients with and without
paroxysmal atrial fibrillation
(PAF)
Patient characteristics PAF, N = 21 No AF, N = 142 p
Age (years) 81 ± 9 67 ± 15 <0.001
Sex, female 8 (38) 53 (37) 0.946
Current smoking 1 (5) 20 (14) 0.234
Hypertension 17 (81) 95 (67) 0.195
Diabetes 3 (14) 24 (17) 0.763
Dyslipidemia 7 (33) 54 (38) 0.678
Previous AF/PAF diagnosis 5(24) 8 (6) 0.004
Antiarrhythmic drugs 11 (52) 35(25) 0.009
CHA2DS2-Vasc
Median 5 4.5
25th percentile 4 3 0.013
75th percentile 6 6
NIHSS 7 ± 7 4 ± 5 0.146
QTc (ms) 458 ± 30 432 ± 34 0.002
Thrombolysis 3 (15) 20 (14) 0.922
Left atrial volume
Normal (< 40 mL/m2) 9 (50) 77 (72)
Enlarged (40–45 mL/m2) 4 (22) 14 (13) 0.175
Severely enlarged (> 45 mL/m2) 5 (28) 16 (15)
Not available 3 35
Left atrial diameter
Normal (< 39 mm) 2 (18) 43 (41) 0.296
Enlarged (39–50 mm) 8 (73) 51 (50)
Severely enlarged (> 50 mm) 1(9) 9 (9)
Not available 10 39
SRA risk score
High-risk score 20 (95.2%) 32 (22.5%) < 0.001
Table 3 Multivariate analysis
Patient characteristics Hazard
Ratio
Lower 95%
CI
Higher 95%
CI
p
Previous AF/PAF diagnosis 4.27 0.84 21.7 0.080
CHA2DS2-VASC score 0.96 0.56 1.63 0.870
High-risk score SRA 70.1 7.8 632 0.000
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Fig. 1 Examples of RR interval variability during continuous cardiac
monitoring. Each plot represents 1 h of monitoring (the Lorentz plots:
each RR interval is plotted as a function of the preceding RR interval). a
Transitioning from low to high AF risk. b Transitioning from high risk to
manifest AF. c Transitioning from high risk to low risk. AF atrial
fibrillation, s seconds, Risk SRA clinic risk grade for atrial fibrillation.
0 = low risk; 3 = high risk; 4 =manifest AF (see the BMethods^ section)
Transl. Stroke Res.
Our results are in accordance with the previously published
studies. In our cohort, the total AF rate was 29%, while PAF
was detected in 16.5% of cases. In a recent global survey [10],
the AF prevalence among acute stroke patients was 28%while
in two systematic reviews, the expected yield of detecting PAF
in a standard SU setting was estimated to be 14.7 [1, 2]. Bettin
et al. [11] applied SRA analysis to 106 patients with acute
stroke of unknown etiology. These patients were followed
up with an implantable loop recorder. On long-term monitor-
ing, 13 patients with PAF were detected, 4% in the low-risk
group and 33% in the high-risk group.
Rizos et al. [12] investigated 136 acute stroke patients apply-
ing SRA analysis to 1–2 h ECG recordings obtained in emer-
gency room. The patients were then followed with CCM for ≥
48 h after SU admittance. SRA stratified 70/136 patients as low
risk and in 7/70 of these PAF was subsequently detect at CCM
(this accounting for a false negative rate of 10%). In our sample,
only 1/111 patient of the low-risk group developed PAF. This
difference between the two studies may depend on the fact that
we stratified the PAF risk analyzing with SRA 48 h of CCM
rather than 1–2 h of ECG recordings. In fact, RR dynamics, as
Rizos et al. [12] found, can consistently vary within contiguous
hours (Fig. 1), and thus, the evaluation of longer time periods
might provide a more accurate PAF risk. Interestingly, 14/34
patients classified at high risk in the study were then diagnosed
with PAF, a similar percentage as in our sample (41 vs 38%).
Themain limitation of this studywas the lack of a predefined
standard amount of ECG recordings for AF detection. After the
first 48 h CCM, the use of additional ECGs, a Holter ECG, or
further CCM for the detection of PAFwas not standardized and
left to the discretion of the treating physicians. Some patients
(for example those with more severe strokes) may have re-
ceived longer CCM and more ECGs/Holter ECGs than others
and this may have led to increased opportunities for PAF detec-
tion. We did not report the duration of the detected PAF epi-
sodes. As pointed out by Kishore et al., in clinical acute stroke
studies PAF is frequently poorly defined and there is a lack in a
clear distinction between AF/PAF as well as in reporting the
length of PAF episodes. The estimation of AF burden might be
more important in primary than in secondary stroke prevention.
Finally, our multivariate model must be considered exploratory
as the relatively small sample size and several factors were
associated in univariate analysis with the presence of AF.
In conclusion, using standard CCM monitoring and appli-
cation of a commercial software algorithm, we have found
that acute ischemic stroke patients with increased RR dynam-
ics are at higher risk of PAF during stroke unit admission. This
information could be of value to decide on longer term mon-
itoring within the stroke unit hospitalization.
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